Citation Impact
Citing Papers
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.
1983
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: A dilemma and a challenge
1981
Does the Early Administration of Beta‐blockers Improve the In‐hospital Mortality Rate of Patients Admitted with Acute Coronary Syndrome?
2010
A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
2005 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
A Risk-Benefit Assessment of Celiprolol in the Treatment of Cardiovascular Disease
1994
Random-effects model for meta-analysis of clinical trials: An update
2006 Standout
The Thrombospondins
2011 Standout
Early intravenous beta-blockers in patients with acute coronary syndrome—A meta-analysis of randomized trials
2012
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: Cartilage oligomeric matrix protein counteracts type IX collagen–induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures
2009
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Cardiac protection during acute myocardial infarction: Where do we stand in 2004?
2004
The IL-1β/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis
2016
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
2009 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Practical methods for incorporating summary time-to-event data into meta-analysis
2007 Standout
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
2005 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Meta-analysis: Principles and procedures
1997 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
PREVENTION OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION BY INTRAVENOUS PROPRANOLOL
1984
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Parameter estimation approach for particle flow model of rockfill materials using response surface method
2015
Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts.
1980
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
2005 Standout
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials
1986
Quantitative Synthesis in Systematic Reviews
1997 Standout
Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
1980 Standout
PROTECTIVE EFFECT OF PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTION
1978
EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION
1980
Meta‐analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co‐operative trials
1987
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
The stunned myocardium: prolonged, postischemic ventricular dysfunction.
1982 Standout
BETA‐BLOCKADE IN ACUTE MYOCARDIAL INFARCTION: INABILITY OF RELATIVELY LATE ADMINISTRATION TO INFLUENCE INFARCT SIZE AND ARRHYTHMIAS
1981
Effect of very early intervention with metoprolol on myocardial infarct size.
1983
Reduction in Infarct Size, Arrhythmias, Chest Pain and Morbidity by Early Intravenous β-Blockade in Suspected Acute Myocardial Infarction
1983
Efforts to Limit the Size of Myocardial Infarcts
1981
Propranolol during the evolution and subsequent ten days of myocardial infarction in man: Hemodynamic, initial cardiac energetic, and neurohumoral responses
1979
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse
1998 StandoutNobel
Blood pressure, stroke, and coronary heart disease
1990 Standout
Effect of Propranolol on Myocardial-Infarct Size in a Randomized Blinded Multicenter Trial
1984
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Medical and surgical management of myocardial infarction
1979
EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTION
1979
Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.
1980
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.
1981
Overexpression of the Cardiac β2-Adrenergic Receptor and Expression of a β-Adrenergic Receptor Kinase-1 (βARK1) Inhibitor Both Increase Myocardial Contractility but Have Differential Effects on Susceptibility to Ischemic Injury
1999 StandoutNobel
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Review: Calibration of the discrete element method
2017 Standout
The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs.
1979
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol
1982
Reduction of infarct size with the early use of timolol in acute myocardial infarction
1984
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release.
1984
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
1998 StandoutNobel
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Daniel Howell being referenced
Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin
2008
Reduction of enzyme levels by propranolol after acute myocardial infarction.
1978
The potential use of a Gadget model to predict stock responses to climate change in combination with Bayesian networks: the case of Bay of Biscay anchovy
2011